Sort
40,608 grants matching “prostate cancer”
Role of long non-coding RNAs in sarcoma pathogenesis
$400,745Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2018 · CA
Structural Mechanisms of Hedgehog Autoprocessing in Physiology and Disease
$400,728Chunyu Wang · Rensselaer Polytechnic Institute · R01 · FY2017 · CA
3D Prostate Histochemometry to Predict Disease Recurrence
$400,626Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2017 · CA
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
$400,622Brent K. Hollenbeck · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
3D Prostate Histochemometry to Predict Disease Recurrence
$400,610Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2018 · CA
Activation of latent TGF-beta by integrins
$400,606John S. Munger · New York University School Of Medicine · R01 · FY2007 · HL
The Therapeutic Potential, Pharmacology and Toxiciity of Promising Small-Molecule
$400,543Kenneth J. Pienta · University Of Michigan At Ann Arbor · U19 · FY2008 · CA
Hardwiring Mechanism into Predicting Cancer Phenotypes by Computational Learning
$400,481Luigi Marchionni · Johns Hopkins University · R01 · FY2016 · CA
Suicide Gene and Radiation Therapy Clinical Trials
$400,357Henry Ford Health System · P01 · FY2005 · CA
Effects of Arsenic on Human Prostate Stem Cells and Prostate Cancer Risk
$400,346Gail S Prins · University Of Illinois At Chicago · R01 · FY2015 · ES
Racial Differences in Prostate Cancer Molecular Subtyping
$400,313Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2018 · CA
Racial Differences in Prostate Cancer Molecular Subtyping
$400,313Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2021 · CA
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
$400,313Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
$400,313Steven P. Balk · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
Role of CEACAM1 in Epithelial Cell Polarization
$400,270John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2007 · CA
Plasma and saliva biomarkers of disease status in HPV related oropharynx cancer
$400,268Joseph A Califano · University Of California, San Diego · R01 · FY2020 · CA
Role of CEACAM1 in Epithelial Cell Polarization
$400,219John E. Shively · Beckman Research Institute/City Of Hope · R01 · FY2006 · CA
Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy Resistance
$400,194Ping Mu · Ut Southwestern Medical Center · R37 · FY2023 · CA
Genetics of Prostate Cancer Risk &Agressiveness
$400,150Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2003 · CA
Ethnicity & Determinants of QoL Following PCa Treatment
$400,135Frank J Penedo · University Of Miami Coral Gables · R01 · FY2007 · CA
Community Clinical Oncology Program
$400,119Northshore Univ Healthsystem Res Inst · U10 · FY2004 · CA
Plasma and saliva biomarkers of disease status in HPV related oropharynx cancer
$400,118Joseph A Califano · University Of California, San Diego · R01 · FY2021 · CA
Molecular Recognition of Proteins and Ligand Design
$400,109William Jorgensen · Yale University · R01 · FY2023 · GM
Molecular Recognition of Proteins and Ligand Design
$400,109William Jorgensen · Yale University · R01 · FY2022 · GM
Molecular Recognition of Proteins and Ligand Design
$400,109William Jorgensen · Yale University · R01 · FY2021 · GM